FCS Press Releases

Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to announce that Board-certified hematologist and medical oncologist William T. McGarry, MD has joined the statewide practice. He is providing care to patients in Indian River County at the Sebastian clinic, 13060 US Highway 1, Sebastian, Florida 32958 and at the Vero Beach East clinic, 3730 7th Terrace, Suite 101, Vero Beach, Florida 32960.

Ray Bailey, BPharm, RPh, Senior Vice President of Pharmacy Services for Florida Cancer Specialists & Research Institute, LLC (FCS), will retire on December 31, 2022. Bailey joined the statewide practice in 2009 and has been instrumental in developing its comprehensive Pharmacy Services division. 

FCS hematologists and oncologists were contributors to several presentations at the San Antonio Breast Cancer Symposium®.

Research conducted at Florida Cancer Specialists & Research Institute is contributing to global advancements in the diagnosis and treatment of blood diseases.

FDA approval of a new immunotherapy treatment improves outcomes for patients with metastatic non small-cell lung cancer.

Florida Cancer Specialists & Research Institute, LLC (FCS) welcomes Robert Ferdman, MD to the statewide practice.  He is providing care to patients in Clay County at the Fleming Island clinic, 4689 US Highway 17, Suite 2, Fleming Island, Florida 32003.

Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to welcome two experienced senior leaders to its Finance team – Christopher Jenkins, Vice President of Financial Planning & Analysis and Tara Lambert, Vice President & Controller, Accounting.

FCS takes exception to a recent study published suggesting that colonoscopies are not as effective at preventing colorectal cancer deaths as previously thought. 

Florida Cancer Specialists & Research Institute, LLC (FCS) celebrated the groundbreaking for its new clinical site location in Davenport, FL, yesterday. The new clinic will be located at 2050 Holly Hill Fruit Rd., Davenport, FL.  33837, and will boast nearly 15,000 square feet and offer a broad range of treatments and services for patients with cancer and blood disorders, including medical oncology/hematology, infusions, radiology, an in-house laboratory and pharmacy, and care management services.

Florida Cancer Specialists & Research Institute, LLC (FCS) medical oncologist Scott Tetreault, MD is being honored as a Heart of Gold Recognition Award recipient by the Association of Fundraising Professionals (AFP) Big Bend Chapter for his notable efforts to benefit the Tallahassee community.

Diane Cope, PhD evaluates the bone health of men with prostate cancer undergoing androgen deprivation therapy.

Florida Cancer Specialists & Research Institute (FCS) welcomes Board-certified medical oncologist Ke Ning, MD to the Sarasota Downtown clinic team. Dr. Ning joined the statewide practice in 2020 and has been serving as a hospitalist in the Sarasota community.

A study conducted by Florida Cancer Specialists & Research Institute, LLC (FCS) evaluating the use of a new therapy to improve chemotherapy treatment outcomes was published in the October issue of the International Journal of Cancer Care and Delivery.

Michael Diaz, MD, President & Managing Physician of Florida Cancer Specialists & Research Institute, LLC (FCS), will participate as a panelist for the Patient-Centered Oncology Care® (PCOC) conference presented by The American Journal of Managed Care® (AJMC) on November 9 – 10, 2022 in Nashville, TN.

Florida Healthcare Specialists (FHS), a division of Florida Cancer Specialists & Research Institute, LLC (FCS), held a ribbon-cutting ceremony on November 3, 2022 to celebrate the opening of a new clinical site in Vero Beach, FL, dedicated to urologic care.

Physicians and leaders of Florida Cancer Specialists & Research Institute, LLC (FCS) joined key influencers and oncology care professionals at the 2022 National Community Oncology Dispensing Association (NCODA) International Fall Summit held in Orlando, Oct. 27 – 29.